Does Linaclotide work?
Yes, in large controlled trials of about 800 people each.
The adult IBS-C approval rests on two phase 3 randomized placebo-controlled trials with about 800 patients each (1,604 in total, per the label); the cited 2012 paper reports the 26-week trial of 804 patients. Two further trials support chronic constipation, and the pediatric extensions rest on additional randomized trials. Head-to-head comparisons with other secretagogues such as plecanatide are missing. 12
Two phase 3 trials randomized a combined 1,604 adults with IBS-C to linaclotide or placebo. One lasted 12 weeks plus a 4-week withdrawal period. The other lasted 26 weeks. In the 26-week trial, reported by Chey and colleagues, 804 patients were evaluated. The FDA's combined measure had two parts. Patients needed at least 30 percent less abdominal pain. They also needed at least one more complete spontaneous bowel movement per week. Both had to hold in at least 6 of the first 12 weeks. By that measure, 33.7 percent of linaclotide patients responded versus 13.9 percent on placebo. Differences from placebo held through 26 weeks. 12
The chronic constipation and pediatric trials summarized in the label show the same pattern. People had more complete spontaneous bowel movements per week than on placebo. The main cost was diarrhea. 2
Evidence checklist
- Randomised controlled trial Two phase 3 placebo-controlled trials
- Human study over 100 people 1,604 patients across the IBS-C trials
- More than one research group Trials mainly from the sponsors
- Clinical outcomes, not surrogate markers Bowel movements and abdominal symptoms
- Human safety data beyond case reports Large trials, boxed warning under age 2
Read the full Linaclotide page
More on Linaclotide
Citations
- Chey 2012, Am J Gastroenterol: linaclotide for irritable bowel syndrome with constipation, 26-week randomized placebo-controlled trial doi.org
- AbbVie: Linzess US prescribing information, revised 2026 rxabbvie.com
Reference information only, not medical advice. Drawn from the Linaclotide article, fact-checked against the cited sources. No dosing anywhere on this site.